By Canntab Therapeutics Ltd on Friday, 20 April 2018
Category: Pharmaceutical - BioTech

Canntab Therapeutics debuts shares on 'serendipitous' 4/20

Jeff Renwick, CEO of (CSE: PILL) tells Proactive Investors that the company that produces oral marijuana tablets is going public on the same day it was incorporated two years ago, and a day that pot enthusiasts celebrate as "Weed Day."

Renwick says as part of the strategic initiative to go public, the company plans to roll out a product development line and will next execute its distribution plan.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Canntab Therapeutics Ltd named herein, including the promotion by the Company of Canntab Therapeutics Ltd in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Related Posts